BSEResult22h ago · 10 Nov 2026, 11:30 pm
Results-Financial Results for Quarter and Half Year ended 30 September 2026
Suraksha Diagnostic Ltd · 544293
✦ AI SummaryResults
Suraksha Diagnostic Ltd announced its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors. The results are available on the company's website and have been made available to the stock exchanges.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Suraksha Diagnostic Ltd - 544293 - Results-Financial Results For Quarter And Half Year Ended 30 September 2026
Attachments (1)
📄pdf
Download →
7d836906-56c0-4863-9c24-10b9c2774751.pdf
View document text
Date: 10th November, 2026
The Secretary The Secretary
BSE Limited The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block
Dalal Street Bandra - Kurla Complex, Bandra (East)
Mumbai - 400 001 Mumbai- 400 051
Scrip Code: 544293 Scrip Symbol: SURAKSHA
Dear Sir / Ma’am,
Sub: Outcome of the Board Meeting held today i.e. Tuesday, 10th November, 2026
Ref: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (‘Listing Regulations’) as amended from time to time
Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 33 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) as amended
from time to time, we wish to inform you that the Board of Directors of the Company, at its meeting
held today, i.e. Tuesday, 10th November, 2026, inter alia, considered and approved/noted the
following:
1. Approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the
quarter and half year ended September 30, 2026 and the same is enclosed along with the Limited
Review Report issued by the Statutory Auditors of the Company, pursuant to Regulation 33 of
SEBI Listing Regulations marked as “Annexure-A”;
The aforesaid financial results are also being made available on the Company’s website at
www.surakshanet.com.
Please note that the meeting commenced at 03:00 P.M. (IST) and concluded at 03:40 P.M. (IST)
You are requested to take the same on record.
Thanking you.
For Suraksha Diagnostic Limited
Shreya Arora
Company Secretary & Compliance Officer
Membership No.: 30892
Encl.: as above
Suraksha Diagnostic Limited
(Formerly known as Suraksha Diagnostic Private Limited)
CIN: L85110WB2005PLC102265
Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New
Town, Kolkata-700 156, West Bengal, India
E-mail: investors@surakshanet.com I Website: www.surakshanet.com
Phone:(033) 6605 9750